Vigorous growth in the first half of 2022
Preliminary results: Revenue +10% – EBITDA +19%
Preliminary results: Revenue +10% – EBITDA +19%
The Board of Directors of GPI S.p.A. examined today the preliminary consolidated results for the first half of 2022, which have not yet been independently audited.
This figures confirm the Group’s vigorous action to support the digitalisation of healthcare systems, which have proven to be a fundamental hub of countries’ socio-economic and healthcare balance.
Growth, which was almost entirely organic, occurred in a counter-cyclical, defensive sector that challenges markets in turmoil as a result of a set of unfavourable global events.
€52 million contract for software, services, and artificial intelligence.
On November 21 at the CIC Forum 2024, November 27 at the European Midcap, and December 3 at the Mid & Small in Milan
Innovation and technology for a new cell therapy supply chain.